Followers | 227 |
Posts | 13143 |
Boards Moderated | 0 |
Alias Born | 09/26/2011 |
Monday, May 22, 2017 5:42:51 PM
The Company has not generated significant revenues from operations to date. The Company has an accumulated deficit of $1,322,136 as of March 31, 2017.
To the extent that the Company's capital resources were insufficient to meet operating requirements, the Company has had extensive talks with European investors to obtain loan funding for its future needs. If the company is unsuccessful in this endeavor, they have obtained access to additional funds through a $2 million equity financing agreement with Kodiak Capital, which may have the effect of diluting the holdings of existing shareholders.
Recent ASCK News
- Form 8-K - Current report • Edgar (US Regulatory) • 07/25/2023 01:47:37 PM
- Form 253G2 - • Edgar (US Regulatory) • 07/21/2023 10:02:42 AM
- Form QUALIF - Notice of Qualification [Regulation A] • Edgar (US Regulatory) • 07/06/2023 04:15:10 AM
- Form 1-A/A - Offering Statement [Regulation A]: [Amend] • Edgar (US Regulatory) • 06/30/2023 04:09:04 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM